[Drug therapy of coronary insufficiency].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D002118:Calcium / Q000037:antagonists & inhibitors; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002866:Chromonar / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels; D006801:Humans; D008875:Middle Aged; D009566:Nitrates / Q000627:therapeutic use; D010099:Oxyfedrine / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D002301:Cardiac Glycosides; D009566:Nitrates; D014665:Vasodilator Agents; D010099:Oxyfedrine; D002866:Chromonar; D002118:Calcium
Medikamentöse Therapie der Koronarinsuffizienz.